![Ioannis ANYFANTIS | Project Manager | PhD | European Agency for Safety and Health at Work (EU-OSHA), Bilbao | Prevention and Research Unit Ioannis ANYFANTIS | Project Manager | PhD | European Agency for Safety and Health at Work (EU-OSHA), Bilbao | Prevention and Research Unit](https://i1.rgstatic.net/ii/profile.image/405958665752577-1473799496749_Q512/Ioannis-Anyfantis.jpg)
Ioannis ANYFANTIS | Project Manager | PhD | European Agency for Safety and Health at Work (EU-OSHA), Bilbao | Prevention and Research Unit
![PDF) Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma PDF) Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma](https://i1.rgstatic.net/publication/26864838_Anti-CV2_associated_cerebellar_degeneration_after_complete_response_to_chemoradiation_of_head_and_neck_carcinoma/links/588c4c7ba6fdcc8e63c9112a/largepreview.png)
PDF) Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma
![Images of Athens from the Benaki Museum's Photographic Archives» at the Athens International Airport - Hellenic News of America Images of Athens from the Benaki Museum's Photographic Archives» at the Athens International Airport - Hellenic News of America](https://hellenicnews.com/wp-content/uploads/2018/03/fabm.jpg)
Images of Athens from the Benaki Museum's Photographic Archives» at the Athens International Airport - Hellenic News of America
![PDF) Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG) PDF) Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)](https://i1.rgstatic.net/publication/5468573_Gemcitabine_plus_Oxaliplatin_GEMOX_in_Pretreated_Patients_with_Advanced_Ovarian_Cancer_A_Multicenter_Phase_II_Study_of_the_Hellenic_Oncology_Research_Group_HORG/links/53ef9ceb0cf2711e0c42f580/largepreview.png)
PDF) Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)
Ioannis Spyridon Louzis - Deputy Head of Mission and Consul at the Greek Embassy in Tehran - Ministry for Foreign Affairs of the Hellenic Republic | LinkedIn
![Lambros ATHANASIOU | PostDoc Position | Phd | Massachusetts Institute of Technology, MA | MIT | Harvard-MIT Biomedical Engineering Center Lambros ATHANASIOU | PostDoc Position | Phd | Massachusetts Institute of Technology, MA | MIT | Harvard-MIT Biomedical Engineering Center](https://i1.rgstatic.net/ii/profile.image/654482941673477-1533052301490_Q512/Lambros-Athanasiou-2.jpg)
Lambros ATHANASIOU | PostDoc Position | Phd | Massachusetts Institute of Technology, MA | MIT | Harvard-MIT Biomedical Engineering Center
![Lambros KOKOKIRIS | Assistant Professor | Assοciate Professor | International Hellenic University, Thérmi | Nutritional Studies and Dietetics Lambros KOKOKIRIS | Assistant Professor | Assοciate Professor | International Hellenic University, Thérmi | Nutritional Studies and Dietetics](https://www.researchgate.net/profile/Lambros-Kokokiris/publication/347626786/figure/fig2/AS:1014222368542725@1618820864887/Chelon-labrosus-Egg-development-stages-a-fertilized-egg-b-4-lipid-globules-c-d-e_Q320.jpg)